AtonRa Partners’s Regenxbio RGNX Stock Holding History

AtonRa Partners’s Portfolio RGNX Stock Details RGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-60,033	Closed	-$2.05M	–	117
2021 Q1	$2.05M	Buy	60,033 +12,470	+26%	+$532K	0.91%	48
2020 Q4	$2.16M	Buy	+47,563	New	+$1.66M	1.06%	47

Other funds holding RGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AtonRa Partners's RGNX Position: Q2 2021 in Review

AtonRa Partners sold out of Regenxbio (RGNX) in Q2 2021, closing a stake of 60,033 shares — an estimated $2.05M sold.

AtonRa Partners first reported a position in RGNX in Q4 2020 and held it in 2 quarters. The position peaked at $2.16M in Q4 2020. 172 funds tracked by Wall St. Rank hold RGNX as of Q2 2021.

AtonRa Partners reported no remaining Regenxbio position as of Q2 2021 after selling out during the quarter.
AtonRa Partners sold 60,033 Regenxbio shares in Q2 2021, an estimated $2.05M.
AtonRa Partners first reported a position in Regenxbio in Q4 2020 and held it in 2 quarters.
AtonRa Partners's Regenxbio position peaked at $2.16M in Q4 2020.
172 funds tracked by Wall St. Rank held Regenxbio as of Q2 2021.

Based on AtonRa Partners's 13F filing for Q2 2021, filed 12 Aug 2021.